Nanodrugs: optimism for emerging trend of multidrug resistance
Asad U KhanMedical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, IndiaThis is with reference to an article published recently in your journal regarding the antibiotic activity of chitosan-coated silver nanoparticles.1 This is...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6ee9cd1d47e641db80e84ee52c049e6a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6ee9cd1d47e641db80e84ee52c049e6a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6ee9cd1d47e641db80e84ee52c049e6a2021-12-02T01:29:49ZNanodrugs: optimism for emerging trend of multidrug resistance1176-91141178-2013https://doaj.org/article/6ee9cd1d47e641db80e84ee52c049e6a2012-08-01T00:00:00Zhttp://www.dovepress.com/nanodrugs-optimism-for-emerging-trend-of-multidrug-resistance-a10622https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Asad U KhanMedical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, IndiaThis is with reference to an article published recently in your journal regarding the antibiotic activity of chitosan-coated silver nanoparticles.1 This is an inspiring move towards control of infection caused by multidrug-resistant bacteria which has become a serious problem for clinicians and physicians worldwide.2 At the moment, carbapenems are being used as the drugs of choice to combat infections. However, the emergence of carbapenem resistance has changed current remedial approaches in the management of serious infections. One of the latest enzymes, NDM-1 (New Delhi metallo-β-lactamase-1), first identified in a Swedish patient of Indian origin in 2008,3 has been key in the development of resistance to almost all antibiotics. Infection caused by NDM-1 producers is widespread on the Indian subcontinent,4 and is now emerging in the US and other countries throughout the world.5View original paper by Jena and colleagues.Khan AUDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 4323-4324 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Khan AU Nanodrugs: optimism for emerging trend of multidrug resistance |
| description |
Asad U KhanMedical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, IndiaThis is with reference to an article published recently in your journal regarding the antibiotic activity of chitosan-coated silver nanoparticles.1 This is an inspiring move towards control of infection caused by multidrug-resistant bacteria which has become a serious problem for clinicians and physicians worldwide.2 At the moment, carbapenems are being used as the drugs of choice to combat infections. However, the emergence of carbapenem resistance has changed current remedial approaches in the management of serious infections. One of the latest enzymes, NDM-1 (New Delhi metallo-β-lactamase-1), first identified in a Swedish patient of Indian origin in 2008,3 has been key in the development of resistance to almost all antibiotics. Infection caused by NDM-1 producers is widespread on the Indian subcontinent,4 and is now emerging in the US and other countries throughout the world.5View original paper by Jena and colleagues. |
| format |
article |
| author |
Khan AU |
| author_facet |
Khan AU |
| author_sort |
Khan AU |
| title |
Nanodrugs: optimism for emerging trend of multidrug resistance |
| title_short |
Nanodrugs: optimism for emerging trend of multidrug resistance |
| title_full |
Nanodrugs: optimism for emerging trend of multidrug resistance |
| title_fullStr |
Nanodrugs: optimism for emerging trend of multidrug resistance |
| title_full_unstemmed |
Nanodrugs: optimism for emerging trend of multidrug resistance |
| title_sort |
nanodrugs: optimism for emerging trend of multidrug resistance |
| publisher |
Dove Medical Press |
| publishDate |
2012 |
| url |
https://doaj.org/article/6ee9cd1d47e641db80e84ee52c049e6a |
| work_keys_str_mv |
AT khanau nanodrugsoptimismforemergingtrendofmultidrugresistance |
| _version_ |
1718403022316371968 |